Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 2
1982 6
1983 3
1984 6
1985 7
1986 7
1987 8
1988 8
1989 11
1990 11
1991 8
1992 15
1993 9
1994 15
1995 10
1996 20
1997 29
1998 35
1999 37
2000 49
2001 45
2002 78
2003 64
2004 95
2005 97
2006 93
2007 145
2008 155
2009 190
2010 249
2011 278
2012 326
2013 454
2014 532
2015 573
2016 571
2017 622
2018 723
2019 815
2020 956
2021 1100
2022 790
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

8,258 results
Results by year
Filters applied: . Clear all
Page 1
Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells.
Borriello L, Coste A, Traub B, Sharma VP, Karagiannis GS, Lin Y, Wang Y, Ye X, Duran CL, Chen X, Friedman M, Sosa MS, Sun D, Dalla E, Singh DK, Oktay MH, Aguirre-Ghiso JA, Condeelis JS, Entenberg D. Borriello L, et al. Among authors: ye x. Nat Commun. 2022 Feb 2;13(1):626. doi: 10.1038/s41467-022-28076-3. Nat Commun. 2022. PMID: 35110548 Free PMC article.
Benzyl thioether formation merging copper catalysis.
Xu B, Lin Y, Ye Y, Xu L, Xie T, Ye XY. Xu B, et al. Among authors: ye xy. RSC Adv. 2021 Dec 23;12(2):692-697. doi: 10.1039/d1ra08015f. eCollection 2021 Dec 22. RSC Adv. 2021. PMID: 35425124 Free PMC article.
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations.
Lu S, Dong X, Jian H, Chen J, Chen G, Sun Y, Ji Y, Wang Z, Shi J, Lu J, Chen S, Lv D, Zhang G, Liu C, Li J, Yu X, Lin Z, Yu Z, Wang Z, Cui J, Xu X, Fang J, Feng J, Xu Z, Ma R, Hu J, Yang N, Zhou X, Wu X, Hu C, Zhang Z, Lu Y, Hu Y, Jiang L, Wang Q, Guo R, Zhou J, Li B, Hu C, Tong W, Zhang H, Ma L, Chen Y, Jie Z, Yao Y, Zhang L, Jie W, Li W, Xiong J, Ye X, Duan J, Yang H, Sun M, Sun C, Wei H, Li C, Ali SM, Miller VA, Wu Q. Lu S, et al. Among authors: ye x. J Clin Oncol. 2022 May 17:JCO2102641. doi: 10.1200/JCO.21.02641. Online ahead of print. J Clin Oncol. 2022. PMID: 35580297
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial.
Wang H, Mao L, Yang M, Qian P, Lu H, Tong H, Xie W, Zhou D, Huang X, Wang Y, Xu G, Lu Y, Wei J, Mai W, Ye X, Meng H, Shen Y, Huang J, Yu W, Sun J, Sheng J, Yan X, Jin J, Zhu HH. Wang H, et al. Among authors: ye x. Lancet Haematol. 2022 Jun;9(6):e415-e424. doi: 10.1016/S2352-3026(22)00106-5. Epub 2022 May 2. Lancet Haematol. 2022. PMID: 35512726 Clinical Trial.
Multi-arm covariate-adaptive randomization.
Hu F, Ye X, Zhang LX. Hu F, et al. Among authors: ye x. Sci China Math. 2022 Jul 21:1-28. doi: 10.1007/s11425-020-1954-y. Online ahead of print. Sci China Math. 2022. PMID: 35912316 Free PMC article.
Field deployable impedance-based corrosion sensor.
Li J, Jiang X, Khan F, Ye X, Wang S, Chen J. Li J, et al. Among authors: ye x. Sci Rep. 2022 Jan 7;12(1):236. doi: 10.1038/s41598-021-03840-5. Sci Rep. 2022. PMID: 34996955 Free PMC article.
8,258 results